Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,839 companies covered, latest filing Oct 23.

  • $1.5B bought by 347 insiders at 211 companies
  • $3.3B sold by 273 insiders outside a trading plan
  • $7.9B sold by 829 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past month, each insider's filings added up.

  1. LENLennar
    Berkshire Hathaway Inc.10% owner, +1 joint filer
    4,758,747 shares at $80.46 Sep 23–Oct 2, 3 filings
    $383M
  2. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    6,596,299 shares at $34.18 Sep 21–Oct 20, 21 filings +5.3% to stake
    $225M
  3. KODKodiak Sciences
    Baker Bros. Advisors LPDirector, +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29, 3 filings +11% to stake
    $157M
  4. SAFXXCF Global
    EEME Energy SPV I, LLC10% owner
    119M shares at $1.19 Oct 16 +109% to stake
    $142M
  5. GPIGroup 1 Automotive
    Conifer Management, L.L.C.10% owner
    400,000 shares at $244.51 Sep 24–30, 2 filings +26% to stake
    $97.8M
  6. UUUUniversal Safety Products
    Milton C Ault IIIDirector
    33,434 shares at $2,766.36 Sep 21–30, 2 filings
    $92.5M
  7. GMEGameStop
    Ryan CohenCEO
    1,994,130 shares at $25.29 Sep 29–Oct 13, 3 filings +4.9% to stake
    $50.4M
  8. BORRBorr Drilling
    Tor Olav TroimDirector
    9,500,000 shares at $4.53 Oct 5–15, 7 filings +31% to stake
    $43M
  9. PAMPampa Energia
    Marcos Marcelo MindlinDirector
    435,000 shares at $80.78 Oct 15 +6.4% to stake
    $35.1M
  10. GGRGogoro
    Chung-Yao YinDirector
    14.2M shares at $2.48 Oct 7 New stake
    $35.1M

Biggest sales

Past month, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    86,222 shares at $48,532.59 Oct 7–20, 2 filings 1.1% of stake Planned sale (10b5-1)
    $4.2B
  2. MDLNMedline
    GIC Private Ltd10% owner, +2 joint filers
    28.5M shares at $34.97 Oct 2–8, 2 filings
    $996M
  3. ESTCElastic
    Steven SchuurmanDirector
    3,500,000 shares at $92.43 Oct 5–12, 2 filings 58% of stake
    $323M
  4. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    14.6M shares at $17.33 Oct 6–19, 5 filings 37% of stake
    $253M
  5. AVGOBroadcom
    Henry SamueliDirector
    702,190 shares at $356.04 Sep 23 1.9% of stake Planned sale (10b5-1)
    $250M
  6. THTarget Hospitality
    TDR Capital II Investments LP10% owner, +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  7. ANETArista Networks
    Jayshree UllalCEO
    778,531 shares at $213.68 Sep 25–Oct 9, 4 filings 4.8% of stake Planned sale (10b5-1)
    $166M
  8. KNTKKinetik
    ISQ Global Fund II GP LLC10% owner, +4 joint filers
    2,448,272 shares at $54.63 Sep 22–Oct 13, 4 filings 100% of stake
    $134M
  9. CRWDCrowdStrike
    Burt W. PodbereCFO
    480,000 shares at $261.44 Sep 24 Planned sale (10b5-1)
    $125M
  10. NBISNebius Group
    Ophir NaveCOO
    500,000 shares at $235.53 Oct 5 52% of stake Planned sale (10b5-1)
    $118M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

ALHC insider trades

Every open-market buy and sale in ALHC, one row per filing, newest first

ALHC page
All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $356K 27,400 shares at $13.00 4.4% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  2. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $2.2M 172,600 shares at $12.96 22% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  3. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $70K 5,000 shares at $14.00 0.5% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $4.1M 298,000 shares at $13.88 27% of stake
    Traded Aug 10 Filed Aug 10
    ↗
  5. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $3.7M 177,068 shares at $20.83 16% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  6. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $5.9M 298,000 shares at $19.86 22% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  7. Joseph S Konowiecki EVP, Corporate Affairs
    ALHCAlignment Healthcare
    Planned sale
    $600K 25,000 shares at $24.00 2.2% of stake
    Traded Jul 1 Filed Jul 1
    ↗
  8. Joseph S Konowiecki EVP, Corporate Affairs
    ALHCAlignment Healthcare
    Planned sale
    $575K 25,000 shares at $23.00 2.2% of stake
    Traded Jun 26 Filed Jun 26
    ↗
  9. Joseph S Konowiecki EVP, Corporate Affairs
    ALHCAlignment Healthcare
    Planned sale
    $550K 25,000 shares at $22.00 2.1% of stake
    Traded Jun 18 Filed Jun 18
    ↗
  10. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $586K 30,000 shares at $19.55 3.1% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  11. Hyong Kim Chief Medical Officer
    ALHCAlignment Healthcare
    Planned sale
    $714K 35,951 shares at $19.86 9.8% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  12. Joseph S Konowiecki EVP, Corporate Affairs
    ALHCAlignment Healthcare
    Planned sale
    $525K 25,000 shares at $21.00 2.1% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  13. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $6.1M 298,000 shares at $20.36 18% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  14. Mark D. Kent President - MSO
    ALHCAlignment Healthcare
    Buy
    $198K 14,848 shares at $13.31 New stake
    Traded Jun 2 Filed Jun 2
    ↗
  15. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $483K 30,000 shares at $16.09 2.9% of stake
    Traded May 15 Filed May 19
    ↗
  16. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $5M 298,000 shares at $16.89 17% of stake
    Traded May 11 Filed May 13
    ↗
  17. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $626K 30,000 shares at $20.87 2.8% of stake
    Traded Apr 15 Filed Apr 15
    ↗
  18. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $6.2M 298,000 shares at $20.68 14% of stake
    Traded Apr 10–13 Filed Apr 13
    ↗
  19. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $5.3M 250,000 shares at $21.01 11% of stake
    Traded Apr 7 Filed Apr 8
    ↗
  20. Christopher J Joyce Chief Legal and Admin. Officer
    ALHCAlignment Healthcare
    Planned sale
    $320K 18,013 shares at $17.79 5.6% of stake
    Traded Apr 1 Filed Apr 1
    ↗
  21. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $2.1M 118,000 shares at $17.48 4.8% of stake
    Traded Mar 23 Filed Mar 23
    ↗
  22. Andreas P. Wagner Chief Human Resources Officer
    ALHCAlignment Healthcare
    Planned sale
    $211K 11,602 shares at $18.22 7.2% of stake
    Traded Mar 19 Filed Mar 19
    ↗
  23. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $524K 30,000 shares at $17.48 2.7% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  24. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $3.3M 180,000 shares at $18.19 6.8% of stake
    Traded Mar 10 Filed Mar 10
    ↗
  25. Andreas P. Wagner Chief Human Resources Officer
    ALHCAlignment Healthcare
    Planned sale
    $393K 21,118 shares at $18.62 12% of stake
    Traded Mar 4 Filed Mar 4
    ↗
  26. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $619K 30,000 shares at $20.63 2.9% of stake
    Traded Feb 17 Filed Feb 17
    ↗
  27. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $3.7M 180,000 shares at $20.49 6.4% of stake
    Traded Feb 10 Filed Feb 10
    ↗
  28. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $674K 30,000 shares at $22.48 2.8% of stake
    Traded Jan 15 Filed Jan 16
    ↗
  29. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $3.8M 180,000 shares at $21.11 6% of stake
    Traded Jan 12 Filed Jan 14
    ↗
  30. Hyong Kim Chief Medical Officer
    ALHCAlignment Healthcare
    Planned sale
    $352K 16,506 shares at $21.35 4.7% of stake
    Traded Jan 6 Filed Jan 6
    ↗
  31. Christopher J Joyce Chief Legal and Admin. Officer
    ALHCAlignment Healthcare
    Planned sale
    $213K 10,611 shares at $20.03 3.4% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  32. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $6.9M 328,152 shares at $20.94 24% of stake
    Traded Jan 2–6 Filed Jan 6
    ↗
  33. Dawn Christine Maroney President
    ALHCAlignment Healthcare
    Planned sale
    $2.6M 130,000 shares at $20.01 7.2% of stake
    Traded Dec 12–15 Filed Dec 15, 2025
    ↗
  34. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $3.4M 180,000 shares at $19.02 7.1% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  35. Christopher J Joyce Chief Legal and Admin. Officer
    ALHCAlignment Healthcare
    Planned sale
    $381K 19,706 shares at $19.33 5.7% of stake
    Traded Dec 8, 2025 Filed Dec 8, 2025
    ↗
  36. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $2.9M 180,000 shares at $16.32 6.7% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
    ↗
  37. John E Kao CEO
    ALHCAlignment Healthcare
    Planned sale
    $3.1M 180,000 shares at $17.29 6.2% of stake
    Traded Oct 10, 2025 Filed Oct 14, 2025
    ↗
  38. Hyong Kim Chief Medical Officer
    ALHCAlignment Healthcare
    Planned sale
    $903K 51,379 shares at $17.57 12% of stake
    Traded Oct 9, 2025 Filed Oct 10, 2025
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.